Compound Detail
CHEMBL5286862
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL5286862 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | LWJAKADMMVNITR-NYYWCZLTSA-N |
3
Targets
3
Activities
1
Assay Types
0
PK Parameters
3
Publications
0
Known Names
Molecular Properties
327.3
MW (Da)
2.48
ALogP
5
HBA
2
HBD
84.9
PSA (Ų)
0.35
QED
0
Ro5 Violations
7
Rot. Bonds
Drug Information
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 3 meas. best 6.21
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| MCF7 | IC50 | = | 620.0 | nM | 6.21 | Cytotoxicity against human MCF7 cells assessed as inhibition of cell growth by M... | 32791404 |
| HepG2 | IC50 | = | 620.0 | nM | 6.21 | Cytotoxicity against human HepG2 cells assessed as inhibition of cell growth by ... | 32791404 |
| HCT-116 | IC50 | = | 620.0 | nM | 6.21 | Cytotoxicity against human HCT-116 cells assessed as inhibition of cell growth b... | 32791404 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 32791404 | 10.1016/j.ejmech.2020.112679 | MCF7 | 1 |
| 32791404 | 10.1016/j.ejmech.2020.112679 | HepG2 | 1 |
| 32791404 | 10.1016/j.ejmech.2020.112679 | HCT-116 | 1 |
Data from ChEMBL 36 via Core Engine